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Abstract
Background: The recently-observed trend towards younger stroke patients in Korea raises economic concerns,
including erosion of the workforce. We compared per-person lifetime costs of stroke according to the age of
stroke onset from the Korean societal perspective.
Methods: A state-transition Markov model consisted of three health states (’post primary stroke event’, ‘alive post
stroke’, and ‘dead’) was developed to simulate the natural history of stroke. The transition probabilities for fatal and
non-fatal recurrent stroke by age and gender and for non-stroke causes of death were derived from the national
epidemiologic data of the Korean Health Insurance Review and Assessment Services and data from the Danish
Monitoring Trends in Cardiovascular Disease study. We used an incidence-based approach to estimate the long-term
costs of stroke. The model captured stroke-related costs including costs within the health sector, patients’ out-of-
pocket costs outside the health sector, and costs resulting from loss of productivity due to morbidity and premature
death using a human capital approach. Average insurance-covered costs occurring within the health sector were
estimated from the National Health Insurance claims database. Other costs were estimated based on the national
epidemiologic data and literature. All costs are presented in 2008 Korean currency values (Korean won = KRW).
Results: The lifetime costs of stroke were estimated to be: 200.7, 81.9, and 16.4 million Korean won (1,200 KRW is
approximately equal to one US dollar) for men who suffered a first stroke at age 45, 55 and 65 years, respectively,
and 75.7, 39.2, and 19.3 million KRW for women at the same age. While stroke occurring among Koreans aged 45
to 64 years accounted for only 30% of the total disease incidence, this age group incurred 75% of the total
national lifetime costs of stroke.
Conclusions: A higher lifetime burden and increasing incidence of stroke among younger Koreans highlight the
need for more effective strategies for the prevention and management of stroke especially for people between 40
and 60 years of ages.
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1. Background
K o r e ab e a r sab u r d e no fs t r o k et h a ti sa tl e a s ts i m i l a rt o
that in the western world, highlighted by being the num-
ber one cause of death [1-4]. However, unlike many
western countries, the gravity of this appears to be often
under-appreciated, and risk factors are inadequately con-
trolled in Korea. According to the Korean National Health
and Nutrition Examination Survey (KNHANES), only a
slight reduction in the prevalence of hypertension among
people over 30 years of age has been observed, from 29.1%
in 1998 to 27.9% in 2005 [5,6]. Similarly, the prevalence of
hyperlipidemia for people in the same age group has
hardly changed, from 8.6% in 2001 to 8.2% in 2005. The
quantification of the costs related to stroke in Korea could
highlight the problem and help decision makers assign
greater priority to stroke prevention and management.
Many earlier stroke-costing studies have been limited
to the cost measurement of stroke for one or two years
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any medium, provided the original work is properly cited.following the acute event, instead of estimating the life-
time burden [7-9]. A few studies have estimated the
long-term cost of stroke based on an incidence-based
approach, but none have stratified results according to
the age of onset [10-12]. Since stroke often confers per-
manent disability and recurrence is common, costs
incurred by patients suffering stroke at an earlier age
would be greater compared to those of patients for
whom stroke occurred later in life.
A recent, nationally-representative survey in Korea
found the prevalence of stroke among people in their 40s
had increased by 90.91% (from 0.22% in 1998 to 0.42% in
2005) [9]. Within the same period, stroke prevalence also
increased by 54.76% (from 1.26% to 1.95%) and 58.76%
(from 2.91% to 4.62%) among Koreans aged in their 50s
and 60s, respectively. There was only a modest increase, if
at all, in stroke prevalence among Koreans in their 70s
and older (increase by 22.84% and decrease by 4.86%,
respectively) [5,6]. The fact the age distribution of stroke
patients in Korea is moving toward younger ages indicates
that the future economic burden imposed by stroke on the
Korean community is set to increase.
In the present study, we aimed to estimate the years of
life lost and lifetime costs associated with stroke in Korea,
stratified according to the age of onset. Incidence-based
estimates of the costs of new strokes in Korea were also
projected. The study results are expected to increase
understanding of the magnitude of lifetime economic bur-
den of stroke and to urge public health policy makers to
develop effective prevention and management strategies
for stroke, especially for the middle-aged population.
2. Methods
2.1. Overview of the modeled analysis
We developed a state-transition Markov model with yearly
cycles to simulate the natural history of stroke among ten
gender-and-age specific cohorts of patients [13]. Within
each gender, five ages of onset were considered, 45, 55, 65,
7 5a n d8 5y e a r s ,a n df o l l o w - u pw a ss i m u l a t e du n t i lt h ea g e
of 99 years or death. The structure of the Markov model is
shown in Figure 1. Three health states were included: ‘post
p r i m a r ys t r o k ee v e n t ’, ‘alive post stroke’ and ‘dead.’ All
subjects in each gender-age cohort began the simulation
in the health state ‘post primary stroke event’,w h i c h
represented the time at which the primary stroke had just
occurred; that is, this was the baseline of the model. In the
first year after the primary stroke events, subjects were
exposed to two possible transitions: ‘stay alive’ and ‘die’.
Transition through the ‘die’ state was defined by stroke
associated with death within 12 months following its diag-
nosis. The health state ‘post primary stroke event’ was
occupied only during cycle 1 of the model. Survivors
moved into the health state ‘alive post stroke’, from which
they could make four possible transitions in subsequent
years (cycles): ‘stay alive without recurrent stroke,’‘ non-
fatal recurrent stroke,’‘ fatal recurrent stroke,’ and ‘die
from non-stroke causes.’ Only transition through either of
the first two (non-fatal) transition states led back to the
living health state. The health state ‘dead’ was absorbing.
In each cycle, we calculated the ‘expected cost’ of
stroke multiplying the probability of moving through
each transition state by the cost assigned to that state,
and then summing these. The sum of the expected costs
of all the cycles is therefore the estimated lifetime cost
of stroke.
2.2. Transition probabilities and data sources
The transition probabilities for fatal (Rfs) and non-fatal
recurrent stroke (Rnfs) among people with stroke (i.e.
transition from ‘alive post stroke’ to ‘fatal recurrent
stroke’ or to ‘non-fatal recurrent stroke’) were computed
by age and gender as follows:
p ∗ Rs + (1 − p) ∗ Rn =R t
Rs = {Rt − (1 − p) ∗ Rn}

p
Rnfs =R s ∗ Pnfs
Rfs =R s ∗ (1 − Pnfs)
where p = prevalence of stroke in the general popula-
tion
Rs = risk of recurrent stroke (among people with
prior stroke)
Rn =r i s ko fn e w - o n s e ts t r o k e( a m o n gp e o p l ew i t h -
out prior stroke)
Rt = risk of acute stroke in the general population
Rnfs = risk of non-fatal recurrent stroke (among peo-
ple with prior stroke)
Pnfs = proportion of non-fatal recurrent stroke
(among people with prior stroke)
Rfs = risk of fatal recurrent stroke (among people
with prior stroke)
Gender- and ten-year age-specific epidemiologic para-
meters for the Korean population (p, Rn,R t,P nfs)w e r e
derived from a published report provided by the Korean
Health Insurance Review and Assessment Services
(HIRA) [14]. From the report, stroke was defined
according to World Health Organization criteria, includ-
ing hemorrhagic stroke (international classification of
diseases, 10
th revision codes I60-I62), ischemic stroke
(I63), and non-specific stroke (I64) [15]. In the HIRA
report, ‘risk of acute stroke event in the general popula-
tion (Rt)’ and ‘risk of acute stroke event among people
without stroke (Rn)’ were defined as the attack rate of
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100,000 population and incidence rate of acute stroke
(first-ever) per 100,000 population in 2004, respectively.
The distribution of stroke severity, which is usually mea-
sured using by neurological scales and functional out-
come scales such as Barthel Index, National Institute of
Health Stroke Scale, modified Rankin Scale, Glasgow
Outcome Scale, and the American Heart Association
Stroke Outcome Classification score could not be
reflected in the present study because the needed infor-
mation was not available in the claims data [16,17].
Thus, the severity of stroke was classified as either fatal
or non-fatal by according to age and gender.
Transition from ‘alive, post stroke’ through ‘die from
non-stroke cause’ was defined as the probability of
dying due to reasons other than stroke. Due to a lack of
necessary data to allow for estimation of non-stroke
mortality specifically among Koreans with prior stroke,
we applied data from the Danish Monitoring Trends in
Cardiovascular Disease (MONICA) study regarding
standardized mortality ratios (SMRs) of people post
stroke using the following equation [18]:
Ds =S M R∗ Dt
where, Ds = non-stroke mortality in the population
with prior stroke
Dt = non-stroke mortality in the general population
[19,20]
SMR = standardized mortality ratio of non-
stroke mortality among people with prior stroke
versus mortality of the general population: 1.914
for males and 2.295 for females
Finally, the transition probability for ‘stay alive without
recurrent stroke’ was simply the complement (the value
of it subtracted from one) of the sum of the other two
transition probabilities.
Since we used an incidence-based approach to esti-
mate the long-term costs of stroke, the risks mentioned
above adhere to the rate concept. Thus, we converted
risks (Rfs,R nfs, and Ds) to probabilities as follows [13]:
p=1− e -r t
where p = probability, r = rate, t = length of cycle
Key parameters of the Markov model are presented in
Table 1. As the cycles progressed, relevant input data
such as transition probabilities were updated via life-
table analysis.
2.3. Resource use and costs
The model captured all stroke-related resource use and
costs, including costs within the health sector, patients’
out-of-pocket costs outside the health sector, and costs
resulting from loss of productivity due to morbidity and
premature death. We presented all costs in 2008 Korean
currency value (Korean won = KRW). We did not include
disability payments and other forms of government sup-
port to estimate stroke-related costs because they do not
reflect true societal costs and represent transfers among
certain members of society (i.e., transfer costs). In calculat-
ing future costs, we did not allow for increases in health-
care costs (the average inflation rate in the 2000s was
2.84% in Korea) nor did we discount future costs to the
present value (3% of the discount rate is recommended by
Gold et al.), as these opposing effects were similar in mag-
nitude and hence would have nullified one another [21,22].
Figure 1 Markov model to estimate the life-time cost of patients with stroke.
Kang et al. BMC Public Health 2011, 11:646
http://www.biomedcentral.com/1471-2458/11/646
Page 3 of 10Costs within the health sector
The costs within the health sector consisted of insurance-
covered and insurance-noncovered medical costs, informal
caregiver costs, and transportation costs to visit health
care institutions. Records from the Korean National
Health Insurance (NHI) claims database from 2001 to
2004 were used to identify patients with stroke and
resource use for insurance-covered medical services asso-
ciated with stroke. Since the present study was funded by
the Korea Ministry of Health, Welfare, and Family Affairs,
we were able to obtain the NHI claims data through a for-
mal request process submitted to the Korean National
Health Insurance Corporation. Since Korea has a manda-
tory system for national health insurance, the NHI claims
database contains all medical and prescription drug claims
records for the entire population. All patients aged 45 or
older with at least one claim record of outpatient visits or
hospital admissions, containing a primary or secondary
diagnosis of stroke (ICD 10 code: I60-64) in 2002 were
identified from the NHI claims database. The one-year
period prior to 2002 was set to be a ‘window period,’ such
that patients were defined as incident cases only if they
didn’t have any record of a stroke-related claim during the
window period. We defined the case of non-fatal stroke as
cases without death within one year after the stroke onset.
If patients died within one year after the stroke onset,
these cases were defined as fatal stroke. The NHI claims
database contained de-identified identification number
and we were not able to determine the individual’s iden-
tity. None of protected health information was included in
the received data. All data were stored in a password pro-
tected personal computer.
All costs sourced from 2002 to 2004 were inflated to
the value of 2008 using annual inflation rates of medical
price index for insurance-covered services in Korea [21].
The cost of non-fatal stroke in the first year after its
onset was distinguished from the annual costs after the
first year. The first-year cost of a non-fatal stroke esti-
mated from the NHI claims database was the average
insurance-covered costs in the first year associated with
medical and pharmacy costs among stroke patients who
did not die within one year after stroke onset. We used
the average costs in the second year for a non-fatal
stroke case estimated from the NHI claims data as the
second-year cost of a non-fatal stroke. It was assumed
that beyond the first year after a stroke, annual costs
remained constant until recu r r e n c e[ 2 3 ] .I fas u b j e c t
experienced a recurrence in a particular Markov cycle
that was fatal, then the cost of a fatal stroke was applied
to that cycle. The cost of a fatal stroke estimated from
the NHI claims database was the average insurance-cov-
ered costs associated with medical and pharmacy costs
among stroke patients who died within one year after
stroke onset. If the recurrence was non-fatal, then first-
year cost was applied during that cycle, and subsequent-
year costs applied for the subsequent cycles until death
or recurrence of stroke. The assumption was made that
the costs of a recurrent stroke were the same as costs of
a first-ever stroke [24].
Uninsured costs were computed on the basis of a pub-
lished report for the proportion of uninsured medical
costs among the total medical costs spent to treat stroke
(29.5% for hospital admission and 15.2% for outpatient
visits) [25,26]. Uninsured costs did not include nursing
home costs or caregiver costs outside the hospital sector.
We reflected informal caregiver costs by multiplying
the average length of stay in the hospital by the average
daily wage (56,809 KRW; 1,200 KRW is approximately
equal to 1 US dollar) for women aged between 20 and
50 years in 2005, because women in this age group
Table 1 Key epidemiologic parameters used in the modeled analysis
Age of
stroke
onset
(years)
Prevalence of
stroke in
general
population (%)
Risk of new-onset
stroke among people
without prior stroke/
100,000
Number of stroke cases
(Incidence of stroke in
general population/
100,000)
a
Risk of recurrent
stroke among people
with prior stroke/
100,000
Survival rate
of stroke
within one
year (%)
Risk of non-stroke
mortality in
general
population/100,000
Male
45~54 0.68 176 6,963 (214) 5,742 82.76 417
55~64 1.95 444 11,615 (577) 7,262 70.42 837
65~74 4.15 1,090 16,493 (1,447) 9,696 65.01 2,128
75~84 6.27 2,022 10,043 (2,777) 14,066 45.27 5,265
≥85 6.96 2,840 2,160 (3,845) 17,286 34.31 17,923
Female
45~54 0.47 113 4,288 (135) 4,746 82.90 144
55~64 1.56 287 8,100 (376) 6,004 83.36 283
65~74 3.42 758 16,485 (1,053) 9,374 69.66 823
75~84 5.16 1,570 16,639 (2,314) 15,996 49.57 2,982
≥85 4.86 2,471 5,362 (3,118) 15,789 26.35 14,217
a Incidence of stroke in general population with and without prior stroke
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informal caregiver [19]. Transportation costs were esti-
mated by multiplying the average round-trip transporta-
tion cost to a healthcare institution (891 KRW for
outpatient visits and 2,896 KRW for admission) by the
total number of stroke-related visits or admissions [5,6].
These published round-trip transportation costs
included those of all diseases and were not stroke-speci-
fic. Transportation costs for outpatient visits were lower
than costs for admission because patients usually visit
clinics located nearby for outpatient purposes in Korea,
whereas patients who require hospitalization usually
visit general hospitals.
Considering elderly patients in Korea generally visit hos-
pitals accompanied by caregivers, transportation costs for
a caregiver and informal caregiver costs were summed for
patients older than 65 years of age. Informal caregiver
costs for outpatient visits were computed as a product of
the average number of visits and one-third of the average
daily wage, because it was assumed that an outpatient visit
takes one-third of a day.
Costs outside the health sector
Patients’ out-of-pocket spending outside the hospital was
derived from a patient’s survey undertaken by Lee et al.
in 2004. Information collected included costs associated
with the utilization of long-term care facilities including
nursing homes, medical devices and equipments, com-
mercial caregivers, supplemental drugs, and herbal medi-
cines [27]. The costs of commercial caregivers for stroke
victims that are unable to work and who do not stay in a
hospital were included in this category. Using the gender-
and age-specific ratios of second-year to first-year medi-
cal costs (insurance covered and non-covered costs),
which ranged from 0.13 to 0.38, out-of-pocket spending
for the second year (and beyond) was estimated.
Costs resulting from loss of productivity
The costs of loss of productivity due to absence from work
and premature death were estimated using a human capi-
tal approach only up to the age of 65 years because Korean
people generally retire at that age [28]. The costs for
absence from work was calculated by multiplying the aver-
age daily or hourly wage rates by the number of hospitali-
zation days or hours spent for outpatient visits attributable
to stroke. Premature death costs were obtained from the
expected value of an individual’s future earnings during
the potential years of life lost (PYLL), which was defined
as life expectancy at the age of death and was obtained
from Korean life tables [1,2]. Gender- and ten-year age-
specific average yearly wage was used to compute forgone
future earnings [19,20]. Loss of productivity due to prema-
ture death was applied to patients with fatal strokes and
was not applicable to patients with non-fatal strokes.
Productivity costs of absenteeism and premature mor-
tality associated with stroke were also estimated using
the friction cost approach as a sensitivity analysis [29,30].
The friction period was assumed to be six months
because the unemployment rates in 2008 and 2009 were
between 3.2% and 3.6%, which were much lower than the
average rate (8.3%) among the countries in the Organisa-
tion for Economic Co-operation and Development
(OECD) and that in previous literature which used a
three-month friction period [29-31]. For training expen-
ditures per employee in Korea, we used the estimate
reported by the American Society for Training and
Development. Employers in Asia including India, Indone-
sia, Korea, Malaysia, Pakistan, Philippines, Singapore,
Thailand, and Taiwan responded to have invested an
average of 362 US dollars per employee on training in
2000 [32]. The training costs were extrapolated from
2000 to a 2008 value using the overall annual consumer
price index (129.3 in 2008 based on 2000) [21].
3. Results
3.1. Years of life lost
From the Markov cohort simulation, the average life
expectancy following acute stroke was estimated according
to the age of onset. Years of life lost due to stroke were
calculated by comparing life expectancy of people with
stroke with life expectancy in the age- and gender-
matched general population. On average, when stroke
(fatal or non-fatal) occurred at the ages of 45, 55, 65, 75,
or 85 years for men, the expected years of life lost were
15.57, 14.05, 10.23, 7.40, and 4.46 years, respectively. Over-
all, women lost more years of life than men after a stroke,
with the equivalent age estimates being 17.62, 14.29, 12.61,
9.35, and 5.53 years, respectively. Overall, stroke reduced
life expectancy by 48.42 to 86.48% for men and 46.04 to
88.06% for women (Table 2).
3.2. Lifetime costs
Annual per-person costs of non-fatal stroke among men
aged 45 years or older ranged from 4.8 to 8.4 million
KRW during the first year of episode and from 1.3 to 1.9
million KRW in subsequent years, unless there was a
recurrence (Table 3). For women, costs ranged from 4.9
to 5.4 million KRW in the first year and 0.6 to 1.7 million
KRW in subsequent years (Table 3). For both men and
women, first-year costs decreased as patient age
increased, whereas subsequent year costs trended in the
opposite direction. The detail e dc o s tc o m p o n e n t s( i . e . ,
medical costs, patient’s out-of-pocket costs, loss of pro-
ductivity costs) of the average per-person annual cost
associated with non-fatal and fatal stokes are shown in
Additional file 1, Table S1 and Additional file 1, Table
S2, respectively.
Per-person costs of fatal stroke ranged from 6.1 to
11.4 million KRW for men and from 5.5 to 12.2 million
KRW for women. For the age groups starting at 45 and
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increased the economic burden of fatal stroke to 521
and 141 million KRW for men, and 172 and 54 million
KRW for women, respectively.
According to the Markov cohort simulation, a Korean
man was expected to incur lifetime costs of 200.7 million,
81.9 million, 16.4 million, 9.9 million and 6.5 million
KRW if he suffered a stroke at the age of 45, 55, 65, 75,
or 85 years, respectively (Table 4). The economic impact
of stroke was approximately 12.2 or 5.0 times higher,
respectively, among people 45 or 55 years old compared
with that of 65-year olds. Korean women experiencing
stroke at 45, 55, 65, 75, or 85 years of age were likely to
incur lifetime costs of 75.7 million, 39.1 million, 19.3 mil-
lion, 10.8 million, and 6.2 million KRW, respectively
(Table 4). Women aged 45 or 55 years had approximately
3.9 or 2.0 times higher lifetime costs compared to women
aged 65 years. Male-to-female ratios in lifetime costs
were 2.7 to 2.1 among 45 and 55 year olds, respectively,
but diminished to near unity after 65 years of age.
Sensitivity analyses were performed for 20% ± the
base-case value of the selected variables: standardized
mortality ratio of non-stroke mortality among people
with prior stroke versus that of the general population
(SMR) and cost variables. We also presented the
results of sensitivity analyses using the friction cost
approach. The impact of uncertainty of these variables
on the estimated lifetime cost of stroke is presented in
Table 4.
By applying the estimated incidence rate of stroke in
2004 to the national population for each age and gender
stratum of the same year, we projected the total number
of incident strokes [1,2,12]. Multiplication of the total
number of incident strokes by per-capita lifetime cost of
stoke yielded a 4.4 trillion KRW lifetime economic bur-
den attributable to stroke occurring in 2004.
Table 2 Estimated years of life lost due to stroke
Age of stroke
onset (years)
Life expectancy in general
population (years)
a
Estimated life expectancy in
patients with stroke
b
Years of life lost
due to stroke
c
Reduction in life expectancy
due to stroke (%)
Male
45 32.16 16.59 15.57 48.42
55 23.6 9.55 14.05 59.54
65 15.8 5.57 10.23 64.78
75 9.42 2.02 7.40 78.60
85 5.16 0.70 4.46 86.48
Female
45 38.28 20.66 17.62 46.04
55 28.9 14.61 14.29 49.44
65 19.9 7.29 12.61 63.36
75 11.91 2.56 9.35 78.51
85 6.28 0.75 5.53 88.06
a Data source: Korea National Statistical Office, 2005;
b Estimated from Markov cohort simulation;
c Years of life lost due to stroke = (life expectancy in general
population - estimated life expectancy in patients with stroke).
Table 3 Average per-person annual costs associated with stroke
Age of stroke onset (years) Costs of non-fatal stroke
(1
st year)
Costs of non-fatal stroke
(2
nd year)
Costs of fatal stroke
(including premature death costs)
Male
45 8,449 1,250 10,543 (521,179)
55 7,324 1,564 11,366 (141,230)
65 5,134 1,530 8,724
75 4,772 1,946 7,490
85 5,075 1,804 6,143
Female
45 5,358 629 12,182 (171,802)
55 5,032 1,004 9,955 (54,111)
65 4,891 1,309 11,135
75 4,915 1,656 7,993
85 4,669 1,588 5,514
Unit: 1,000 Korean won; All costs are presented in 2008 Korean currency value (1,200 Korean won = 1 US$); Detailed cost components are presented in
Additional file 1, Table S1 and Additional file 1, Table S2.
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national economic burden of stroke by various ages.
While people in the 45 to 54 and 55 to 64 year age
groups accounted for only 11% and 19% of incident
strokes, respectively, they accounted for 44% and 31% of
the national lifetime costs of stroke. In contrast, Koreans
aged 65 years and above contributed to 70% of incident
strokes but accounted for only 25% of the national life-
time costs of stroke.
4. Discussion
T h i ss t u d yi st h ef i r s tt oe s t i m a t et h el i f e t i m ec o s t so f
stroke in Korea. Previous studies mostly measured the
annual cost of stroke using a prevalence-based approach
or were limited to the estimations of costs over the
short-term (one or several years following the event)
[27,33]. Since half of the survivors from stroke are left
with permanent disability and consequently bear a life-
time burden, an incidence-based approach has the advan-
tage of providing a more comprehensive picture of the
health and economic impact of stroke [34].
The present study showed how the cost of stroke varied
according to the age of onset. As commonly observed in
earlier studies, per-capita lifetime costs were greater in
younger stroke patients mainly due to long-term man-
agement and loss-of-productivity costs [12]. In the pre-
sent study, the expected lifetime cost of stroke for men
experiencing acute stroke at the age of 45 years was esti-
mated as 200.7 million KRW, whereas that for men 65
years of age was 16.4 million KRW, a difference greater
than 12-fold. Although the difference was less compared
to that of men, the lifetime costs for women suffering
stroke at 45 years (75.7 million KRW) were still
approximately 3.9 times higher than those for women
suffering stroke at 65 years (19.3 million KRW).
It has been observed that the average age of new-onset
stroke is decreasing in Korea. While the proportion of
stroke patients aged in their 70s and 80s has increased by
22.84% and decreased by 4.86%, respectively, between
1998 and 2005, the proportion of patients in their 40s and
50s has increased by 90.91% and 54.76%, respectively [1].
The trend toward younger stroke patients in Korea raises
a concern for the national economy because of an erosion
of the work force. Additionally, the present study showed
that 75% of the national lifetime costs of stroke were attri-
butable to patients aged less than 65 years, although this
age-group accounted for only 30% of incident strokes
(Figure 2). Consequently, if the average age of stroke
patients in Korea continues to decline, then the economic
burden of stroke is expected to increase substantially.
Lifetime costs of stroke are greater among men than
women due to greater indirect costs (i.e., loss of produc-
tivity). The average wage rate in Korea is higher for men
than women. Another possible explanation is that the
value of women working as housewives and caregivers
was not considered, resulting in underestimation of the
productivity loss in women. Notably, medical costs were
also higher among men than women throughout the dif-
ferent age groups, which is different from data from
other countries. For example, according to the summary
of published international data between 1993 and 2003
on the costs of stroke, indirect costs were greater for
men but direct costs were greater for women [12].
Because it is unknown whether males suffer more severe
strokes than females, an unbalanced utilization of
healthcare between the genders is possible.
Table 4 Estimated per-person lifetime costs associated with stroke
Age of stroke onset (years) Base-case analysis: Sensitivity analysis
Lifetime costs of stroke (excluding
premature death costs)
(1) SMR ± 20%
a (2) Cost of illness ± 20%
b (3) Friction cost
approach
Male
45 200,701 (36,301) 196,136~205,354 168,978~232,424 47,125
55 81,914 (24,765) 81,748~82,260 67,974~95,854 33,611
65 16,395 (16,395) 15,479~17,505 14,029~18,762 16,395
75 9,888 (9,888) 9,456~10,432 8,138~11,638 9,888
85 6,543 (6,543) 6,314~6,861 5,235~7,852 6,543
Female
45 75,698 (33,702) 75,454~76,079 64,400~86,997 37,873
55 39,118 (28,052) 38,293~40,086 33,675~44,560 30,948
65 19,261 (19,261) 18,466~20,165 16,558~21,963 19,261
75 10,846 (10,846) 10,449~11,298 8,982~12,709 10,846
85 6,182 (6,182) 6,182~6,182 4,946~7,418 6,182
Unit: 1,000 Korean won; All costs are presented in 2008 Korean currency value (1,200 Korean won = 1 US$);
a SMR: standardized mortality ratio of non-stroke
mortality among people with prior stroke versus general population (Base-case values are 1.914 for males and 2.295 for females. Sensitivity analyses were
performed using the base case value of SMR ± 20%);
b Cost of illness refers to costs of treating non-fatal stroke (costs in first year and second year), costs of
treating fatal stroke, and costs of premature death.
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productivity changes. The human capital approach,
which is widely used, is the traditional approach to mea-
sure and valuate the potential loss of productivity for all
income lost due to absence from work and premature
death. This approach is criticized because the true cost
imposed to society is usually overestimated [28]. The fric-
tion cost approach assumes workers will be replaced after
a certain period of time, called the friction period, and
the amount of lost productivity depends on the time and
cost of replacement. This approach attempts to measure
the actual loss of productivity in the economy and usually
provides much lower estimates for the loss of productiv-
ity than do the estimates from the human capital
approach [28,30]. However, we prefer the human capital
approach for several reasons. First, the objective of the
present study was to evaluate the value of a lost and
damaged human life due to stroke rather than estimating
the actual monetary loss of productivity in the industry.
Second, economic activity returns back to the natural
rate of unemployment in the long-run according to the
macroeconomic theory. Lastly, there are too many uncer-
tainties to estimate the actual loss of productivity using
the friction cost approach because the data about the
friction period and employer costs (i.e., hiring and train-
ing costs) are difficult to estimate. To obtain the esti-
mates of employer costs needed for the friction cost
approach, we searched published literatures and reports
intensively to find Korean data, but failed to identify the
needed estimates. Government organizations in Korea
were also contacted (departments related to human
resources and vocational training in the Ministry of Strat-
egy and Finance and Ministry of Employment and Labor)
to seek expert opinions on the estimates; however, these
searches were unsuccessful. Fortunately, we were able to
find the published report of the American Society for
Training and Development which contained international
comparisons regarding employee training. However,
s i n c et h er e p o r td i dn o ti n c l u d ed a t af o rK o r e ao n l y ,t h e
estimates for Asia (an average of 362 US dollars per
employee on training in 2000) were used, which included
nine countries where the number of included Korean
companies responding to the survey was not known [32].
As expected, the friction cost approach gave us produced
much lower estimates for the loss of productivity (23%
and 41% of the expected lifetime costs of stroke esti-
mated by a human capital approach for men experiencing
acute stroke at the age of 45 and 55 years, respectively).
One of the major strengths of the present study is that
the estimation of the lifetime cost of stroke was based
on national data, both in terms of unit costs (i.e., claims
records of NHI) and epidemiologic information. This
provides greater generalizability of results, compared to
that of earlier studies based on patient records from
selected hospitals or local stroke registries [10,24].
Another strength of the study was the application of
age- and gender-specific cost and epidemiologic data.
Survival rate, recurrence rate, and cost of stroke treat-
ment are well known to be affected by patient age and
gender [12].
A
(11%)
B
(19%)
C
(34%)
D
(28%)
E
(8%)
A
(44%)
B
(31%)
C
(16%)
D
(8%)
E
(1%)
(a) (b)
Figure 2 Age distribution of the incidence (a) and the national economic burden (b) of stroke in Korea.( A :4 5 - 5 4y e a r so l d ,B :5 5 - 6 4
years old, C: 65-74 years old, D: 75-84 years old, E: 85 years old and above).
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that may have led to over or underestimation of stroke
costs. First, due to the lack of data, it was assumed that
the cost for a recurrent stroke was the same as the cost for
the first stroke. However, if the cost of treating a recurrent
stroke was more expensive than the first-ever stroke due
to the increased severity, then the model would have
underestimated the true cost. Secondly, in estimating the
costs associated with premature death, we assumed that
there was no loss of productivity costs after the retirement
age of 65 years. This conservative assumption may also
have contributed to the underestimation of the true costs
of stroke. On the other hand, the universal application of
transportation and loss of productivity costs to all hospital
admissions and office visits due to stroke may have led to
the overestimation of the true costs of stroke. Additionally,
the choice of a human capital approach instead of a fric-
tion cost approach in estimating loss of productivity cost
would cause overestimation of the costs.
The present study has several limitations. First, although
the study has high external validity because of the use of
NHI claims data from the entire population in Korea, case
ascertainment for stroke solely based on diagnostic codes
of insurance claims records may be less accurate com-
pared to a community-based incidence cohort study
[10,24]. The validity issue of administrative database cod-
ing for stroke cannot be easily resolved since the database
is constructed for reimbursement purposes and not for
clinical purposes. However, the NHI claims data has a
higher reliability than any other data in Korea to estimate
the healthcare utilization and costs in terms of representa-
tiveness and generalizability since the NHI claims data
include the entire Korean population. Moreover, the accu-
racy of diagnosis codes tended to be higher for claims of
severe conditions such as stroke compared with those of
other mild conditions [35,36]. In addition, all claims data
in Korea is submitted electronically, thus the precision of
data is higher than that of the paper-based claims data.
Second, due to the lack of detailed epidemiologic data, we
applied the same transition probability of having a recur-
rent stroke regardless of how many cycles or years passed
since the initial stroke. Third, information on patients’
out-of-pocket expense outside the hospital may have lim-
ited generalizability since it was derived from patient sur-
vey results from a selected hospital. Fourth, we were not
able to incorporate the distribution of severity of stroke
measured by neurological scales and functional outcome
scales into the analysis because these clinical values were
not available in the claims database. Ignoring the distribu-
tion of stroke severity may cause distortions in the estima-
tion results of stroke impact.
Last, we did not reflect the value of productivity loss
of housewives with stroke. Moreover, we did not con-
sider the productivity loss of family caregivers, who are
usually women who do not work outside the home and
take care of the stroke victims that are unable to work
and do not stay in hospital. Accordingly, the value of
stroke in Korea may have been underestimated.
Further research is needed to examine whether the
true costs of treatment for stroke patients are different
between the results obtained from the claims database
and from the patient registry data which include clinical
variables representing the severity of stroke.
5. Conclusions
In conclusion, the projected per capita lifetime cost among
patients with stroke substantially varied depending on the
age of onset. Although only 30% of incident stroke occurs
in patients aged 45 to 64 years, this age-group accounts
for over 75% of the national lifetime costs of stroke. This
result confirms the recent trend toward younger stroke
patients in Korea and presents a real economic concern. If
the age distribution of stroke patients in Korea keeps mov-
ing toward younger ages, the future economic burden on
the Korean community imposed by stroke will be substan-
tial. Therefore, more effective strategies and efforts tar-
geted at preventing stroke in the middle-aged population
should be implemented in Korea, in both public health as
well as private clinic settings. Hopefully, the present
national epidemiological study will increase the awareness
of the economic burden of stroke among the younger
population and support public health policy makers in the
development of effective prevention and management
strategies for stroke.
Additional material
Additional file 1: Detailed cost components of the average per-
person annual costs. Table S1 and Table S2 show the detailed cost
components (i.e., medical costs, patient’s out-of-pocket costs, loss of
productivity costs) of the average per-person annual cost associated with
non-fatal stroke and fatal stroke, respectively, by age and gender.
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